Publicações

Selective Inhibition of Bruton?S Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors

AuthID
P-00X-H6X

Author(s)

Sousa, BB

De Almeida, CR

Barahona, AF

Lopes, R

Martins Logrado, A

Cavaco, M

Neves, V

Carvalho, LAR

Labao Almeida, C

Coelho, AR

[+3]·

Castanho, MARB

Neumeister, P

Deutsch, A

Vladimer, GI

Krall, N

Joao, C

Corzana, F

Seixas, JD

Fior, R

Bernardes, GJL

View all authors

Tipo de Documento

Article

Year published

2022

Publicado

in ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, ISSN: 2575-9108

Volume: 5, Número: 11, Páginas: 1156-1168 (13)

Indexing

Wos^®

Scopus^®

Crossref^®3

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1021/acsptsci.2c00163

Pubmed: 36407952

SCOPUS: 2-s2.0-85141952162

Wos: WOS:000914730600001

Source Identifiers

ISSN: 2575-9108

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Sousa, BB;	2	De Almeida, CR;	3	Barahona, AF;
4	Lopes, R;	5	Martins Logrado, A;	6	Cavaco, M;
7	Neves, V;	8	Carvalho, LAR;	9	Labao Almeida, C;
10	Coelho, AR;	11	Bento, ML;	12	Lopes, RMRM;
13	Oliveira, BL;	14	Castanho, MARB;	15	Neumeister, P;
16	Deutsch, A;	17	Vladimer, GI;	18	Krall, N;
19	Joao, C;	20	Corzana, F;	21	Seixas, JD;
22	Fior, R;	23	Bernardes, GJL;

Selective Inhibition of Bruton?S Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Selective Inhibition of Bruton?S Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors

Links Úteis

Ajuda